AstraZeneca has successfully completed the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell ...

AstraZeneca completes acquisition of biotech company, EsoBiotec: Cambridge, UK Wednesday, May 21, 2025, 09:00 Hrs [IST] AstraZeneca announced the successful completion of the acqu ...

Acquisition of EsoBiotec completed AstraZeneca today announced the successful completion of the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has ...

The acquisition, initially announced in March, sees AstraZeneca pay USD425 million up front, with an additional USD575 million in potential milestone payments, bringing the total consideration to up ...

Initial clinical data from this trial are expected to be released in the second half of 2025,” said EsoBiotec Chief Scientific Officer Philippe Parone, PhD. “At ASGCT, we will present the ...

(RTTNews) - European stocks fell from nine-week highs on Wednesday as investors fretted about the lack of progress on trade deal and closely monitored discussions on the U.S. budget bill and ...

Multinational pharmaceutical company AstraZeneca plc has entered into a definitive agreement to acquire the Belgian biotech company EsoBiotec. This is reported in a press release from AstraZeneca. The ...

Apart from four billion-dollar deals valued at $1bn or more driven by large pharma, the industry remains cautious given the uncertainty surrounding US President Donald Trump’s as-yet-unspecified ...